Results 281 to 290 of about 412,569 (303)

Utilization of general practitioners for drug evaluation.

Medical times, 1970
A L, Barlow, P, Marshall
openaire   +1 more source

DRUG UTILIZATION STRATEGIES WITHIN REGIONAL PROGRAMS ON DRUG CONTROL AND EVALUATION

1978
G. Tognoni, C. Bellantuono, F. Colombo, L. Ferrario, M.G. Franzosi, M. Mancini, M. Mandelli   +6 more
openaire   +1 more source

Drug Utilization Strategies within Regional Programs on Drug Control and Evaluation

1979
G. Tognoni, C. Bellantuono, F. Colombo, M.L. Farina, L. Ferrario, M.G. Franzosi, M. Mancini, M. Mandelli   +7 more
openaire   +1 more source

Screening, evaluation, and management of cancer‐related fatigue: Ready for implementation to practice?

Ca-A Cancer Journal for Clinicians, 2015
Ann M Berger, William F Pirl
exaly  

Managing the challenge of chemically reactive metabolites in drug development

Nature Reviews Drug Discovery, 2011
B Kevin Park, Alan Boobis, Nico P E Vermeulen   +2 more
exaly  

Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment

Ca-A Cancer Journal for Clinicians, 1993
Richard T Hoppe
exaly  

The woman at increased risk for breast cancer: evaluation and management strategies

Ca-A Cancer Journal for Clinicians, 1995
Monica Morrow
exaly  

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
exaly  

New Horizons in Drug Delivery

Ca-A Cancer Journal for Clinicians, 1978
exaly  

CANCER PATIENTS AT RISK OF DRUG INTERACTIONS

Ca-A Cancer Journal for Clinicians, 2007
exaly